Cardiovascular Damage in Systemic Lupus Erythematosus Develops Early and Persists Throughout Disease: BMJ
Spain: A recent study published in Lupus Science & Medicine concluded that new damage primarily develops within the first year after a systemic lupus erythematosus (SLE) diagnosis, with cardiovascular issues significant throughout the early and late stages of the disease. Early implementation of strategies to prevent cardiovascular damage is crucial following an SLE diagnosis.
Systemic lupus erythematosus is an autoimmune disease. In this disease, the immune system of the body mistakenly attacks healthy tissue. It affects the skin, joints, kidneys, brain, and other organs. SLE is more common in women than men by nearly 10 to 1. Irene Altabás-González from the rheumatology department, Vigo University Hospital Group, Vigo, Spain, et.al, conducted a study to assess organ damage, especially the cardiovascular system at the different stages of the disease.
For this purpose, the research team conducted a cohort study with 4219 patients enrolled in Spanish Society of Rheumatology Lupus Registry. Using Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) the organ damage was noted. They analyzed 1274 patients over time whose dates of damage events had been recorded.
The findings revealed that:
• In the first year following an SLE diagnosis, 20% of the 1274 patients developed new damage manifestations.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.